Laminomics, presented by founder Alex Dennett, proposed a social media‑style platform where users run short "mini studies," join BioTribes and aggregate crowdsourced health insights. Dennett outlined a multi‑sided revenue model (a $20/month subscription for unlimited mini studies, free limited access for casual users) and said the team plans to raise roughly $500,000 to reach early paying users and scale product and marketing.

Judges and attendees focused on data protection, user comfort and partner access to data. Dennett said the platform will begin with self‑reported data for the minimum viable product, anonymize outputs, and offer opt‑in choices for users who want to share data with research institutions or companies. He said hiring a data privacy attorney and engaging a CTO versed in HIPAA‑compliant apps were priorities.

Dennett estimated an early three‑year target of reaching $1 million in annual recurring revenue by acquiring paying subscribers; judges sought clarity on unit economics, minimum viable product costs and the implications of future partnerships that might share or co‑own data. Dennett told judges he planned to budget roughly $100,000 for the MVP, $300,000 for three‑year marketing, and the remainder for legal and operations.

Organizers awarded Laminomics a top‑three prize; Dennett said he would apply the prize to marketing and legal fees as the team refines privacy controls and partner agreements.